Haemonetics Corp. buy BTIG Research
Start price
21.11.25
/
50%
€67.50
Target price
21.11.26
€76.29
Performance (%)
-16.30%
Price
30.01.26
€56.50
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.30%. This prediction currently runs until 21.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -3.419% | -3.419% |
| iShares Core DAX® | -1.553% | -0.123% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.640% | 5.468% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
-21.53%
30.01.26
30.01.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
-1.74%
30.01.26
30.01.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25